Japanese AI drug discovery company Elix is to work with pharma firm Shionogi & Co to conduct joint research.

Its Stim Assist AI tool provides clinicians with adjunctive information during insemination efforts, while its Embryo Predict tool analyzes patient embryos and helps embryologists prioritize them for transfer.Įlix, Shionogi & Co. The capital will be used to expand its products to clinics and patients globally. The startup's funding round was co-led by existing investor Deena Shakir at Lux Capital and new investors Rebecca Kaden at Union Square Ventures and Anarghya Vardhana at Maveron. The series D funds will be used to scale its platform, as well as add further capabilities to it.Īlife Health, which is developing AI tools to assist physicians in increasing a patient's chances of pregnancy success, has raised $22 million in series A funds. M12, Microsoft’s venture fund, also provided backing for the startup which is building platforms to allow brands to integrate third-party APIs. The round included participation from Citi Ventures, Qumr and Andreessen Horowitz. RapidAPI has raised $150 million in a series D round led by SoftBank Vision Fund 2.

Robotic window cleaner